Navigation Links
Omnicell Announces First Quarter 2011 Results
Date:5/2/2011

Information derived from our December 31, 2010 audited consolidated financial statements.Omnicell, Inc.

Reconciliation of GAAP to Non-GAAP

(In thousands, except per share data, unaudited)Three months endedMarch 31, 2011December 31, 2010March 31, 2010Net incomeEarnings
per share-
dilutedNet incomeEarnings
per share-
dilutedNet income
(loss)Earnings
(loss) per
share-dilutedGAAP$

670$

0.02$

672$

0.02$

979$

0.03Non-GAAP Adjustments:ASC 718 adjustment (a)  Gross Margin367356321  Operating Expenses2,0252,2081,835Litigation settlement, net of tax (b)620Taxes on repatriated foreign earnings383  Total after-tax adjustments3,0120.092,9470.092,1560.06Non-GAAP$

3,682$

0.11$

3,619$

0.11$

3,135$

0.09(a) This adjustment reflects the accounting impact of non-cash stock-based compensation expense related to the impact of ASC 718 (formerly referred to as SFAS No. 123R) for the periods shown.(b) This adjustment is for the accrual of a $1.0 million pre-tax settlement in operating expenses, net of tax effect of $0.4 million. Omnicell, Inc.Calculation of Adjusted EBITDA (1)(In thousands, unaudited)Three Months EndedMarch 31, 2011December 31,2010March 31, 2010GAAP net income $

670$

672$

979Add back:  ASC 718 stock compensation expense2,3922,5642,156  Litigation settlement, pre-tax1,000——  Interest(75)(79)(72)  Depreciation and amortization expense1,8522,1302,123  Income tax expense413995604Non-GAAP adjusted EBITDA (1)$

6,252$

6,2825,790(1) Defined as earnings before interest income and expense, taxes, depreciation and amortization, and non-cash expenses, including stock compensation expense, per ASC 718, formerly FAS 123R. Also excludes the first quarter 2011 non-GAAP adjustment for p
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Leading Hospitals Committed to Healthcares Adoption of GS1 Standards Use Omnicell Solutions for Supply Chain Management
2. Omnicell is First to Demonstrate Automated Dispensing Cabinet Interoperability at HIMSS11 Showcase
3. Omnicell to Present at the UBS 21st Annual Global Healthcare Services Conference
4. Omnicell Announces Fourth Quarter and Full Year 2010 Results
5. Omnicell to Showcase Latest Product Innovations at ASHP
6. Omnicell Announces Third Quarter 2010 Results
7. Omnicell to Release Third Quarter 2010 Earnings Results on October 27
8. Omnicell Acquires Pandora Data Systems
9. Deaconess Health System Selects Omnicells Medication Management System for Product Reliability and Improved Patient Care
10. Wellmont Health System Selects Omnicell for Best-in-Class Medication Management
11. Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will ... the Australian and New Zealand Forensic Science Society,s ... Sciences in Adelaide, Australia . ... concerning the advancements that hyperspectral imaging can bring ... Jeffrey Beckstead , Director of Product Development at ...
(Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today a ... Phase 3 study required for New Drug Application (NDA) ... 140 patients has greater than 90% power to detect ... to enrol additional patients. QRxPharma anticipates completing analysis of ...
... or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that ... clearance from the U.S. Food and Drug Administration (FDA). ... variant of the Unitract™ 1mL Insulin Syringe for which ... syringes which are primarily used by people with diabetes, ...
Cached Medicine Technology:QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR 2QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR 3Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe 2Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe 3
(Date:8/30/2014)... Skmen.com, a well-known clothing manufacturer, has announced its promotion ... middle of September, all the company’s new and old ... 30 percent off. , As a matter of ... made and come with quality guarantees. They can certainly ... popular for its fashionable, high quality clothes for men ...
(Date:8/30/2014)... TX (PRWEB) August 30, 2014 Information ... Pros company to introduce better prices to consumers in ... plans can be found when using the open system ... national lookup system available to use this year can ... insurance based on general location and not from medical ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 ... a Spa-on-Wheels which offers the complete spa experience ... inviting lighting and the most important ingredient of ... "the dedicated licensed pro's! People will enjoy the ... continues Kaplan-Pelle. The website reads, "Step into the ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 Daily ... Carter, called the Make Him Desire You program, who shows ... heart. , The author of this method says that the ... guys. , The Make Him Desire You review indicates that ... reveals amazing insider advice and his great techniques to make ...
(Date:8/30/2014)... August 30, 2014 Daily Gossip reveals in ... Infection is a method created by Sarah Summer, who can ... The author of this new program actually had to deal ... sufferer to be able to access it, in an all-natural ... determination in finding an effective cure for yeast infection. The ...
Breaking Medicine News(10 mins):Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2Health News:Hands On Mobile Massage and Spa of Long Island Now Offers a Spa-on-wheels 2Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2
... Celator Pharmaceuticals today announced that new data ... in consolidation treatment for leukemia and of CPX-1 ... agents for the treatment of colorectal cancer were ... American Association for Cancer Research (AACR) in Denver, ...
... REDWOOD CITY, Calif., April 22 AcelRx Pharmaceuticals, ... Phase 2 clinical trial of ARX-02, a proprietary ... pain control. The primary objective of this multicenter, ... tolerability and efficacy of ARX-02 relative to placebo ...
... OAK BROOK, Ill., April 22 The ... of Minnesota have agreed to conditions for ... receive certain services from DeCare Dental following ... certain business functions that DeCare previously performed ...
... on the list. , ... Newport Beach, CA (Vocus) April 22, 2009 ... of four hospitals in Los Angeles and Orange Counties and one of ... as reported by AARP The Magazine. The designation of a "top hospital" ...
... is committed to providing people with skin care ... practical advice and helpful insights are provided by ... devotion to cosmetic dermatology. The content is written ... wide range of practical advice. Key portions of ...
... its commitment to seniors on Medicaid. New Jersey ... Assisted Living Concepts, revealed a history of evictions when ... , WESTBURY, N.Y., April 22 Raphael Weiss, Managing ... ( www.AmberCourtAL.com ), assured that his ...
Cached Medicine News:Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 2Health News:Celator(R) Pharmaceuticals Presents New Data on CPX-351 And CPX-1 at the American Association for Cancer Research 3Health News:AcelRx Announces Initiation of Phase 2 Cancer Breakthrough Pain Program 2Health News:Delta Dental Plans Association and Delta Dental of Minnesota Agree to Conditions Regarding Supplier 2Health News:Hoag named in top 125 hospitals by Consumers' CHECKBOOK as reported by AARP The Magazine 2Health News:Beauty-Doctors Website Provides Dermatologist-Authored Skin Care Information from Experts 2Health News:Amber Court Assisted Living Communities Reaffirms its Commitment to Seniors on Medicaid 2
... A biopsy with the MAMMOTOME® ... effective, minimally invasive procedure using ... management.,Using computer-generated images to locate ... accurately pinpoint and map the ...
... SEAMGUARD® Staple Line Reinforcement Material is ... postoperative pulmonary air leaks and as ... This inert, biocompatible, ePTFE material requires ... easy to load and fire and ...
... for the repair of abdominal hernias. It ... two distinct sides. One side of ... of sodium hyaluronate and carboxymethylcellulose (similar to ... side is bioresorbable, providing a temporary physical ...
... The Hernia Repair Company, we recognize that ... limited fibrous tissue in-growth between the prosthesis ... polypropylene mesh. Like all the products in ... produces a clinically proven, versatile repair.,The Reconix ...
Medicine Products: